FDA Panel Gives Mixed Message on Lemtrada - MedPage Today

[INCIID News Feed]

Medical Marketing and Media
<img alt="" height="1" width="1" />
FDA Panel Gives Mixed Message on Lemtrada
MedPage Today
Neurology. FDA Panel Gives Mixed Message on Lemtrada. Published: Nov 13, 2013. By Joyce Frieden, News Editor, MedPage Today. save. |. A. A. Take Posttest. SILVER SPRING, Md. -- An FDA advisory committee voted overwhelmingly Wednesday that ...
Sanofi MS Drug Doesn&#39;t Improve Disability, US Panel Says (1)Businessweek
UPDATE 2-FDA panel supports approval of Sanofi&#39;s MS drug LemtradaReuters
Sanofi gets mixed FDA blessing for MS drug LemtradaFierceBiotech
GlobalPost -WHTC
all 12 news articles &raquo;


More...